Nanopublications

Matches in Nanopublications for { ?s ?p "[Both infliximab (chimeric anti-tumor necrosis factor [TNF]-alpha antibody) and etanercept (p75 TNF-alpha receptor/immunoglobulin G fusion protein) are effective against rheumatoid arthritis, but only infliximab induces clinical remission in Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

Showing items 1 to 17 of 17 with 100 items per page.

NP394026.RAkMWo728T2LCU39U_T0lxQ9GMsKKwq27hJSX89dxec8g130_assertion description "[Both infliximab (chimeric anti-tumor necrosis factor [TNF]-alpha antibody) and etanercept (p75 TNF-alpha receptor/immunoglobulin G fusion protein) are effective against rheumatoid arthritis, but only infliximab induces clinical remission in Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394026.RAkMWo728T2LCU39U_T0lxQ9GMsKKwq27hJSX89dxec8g130_provenance.
NP718433.RAnXecGUpsCu0fqvb3SHPEV7ZRXfCKATw6mxpOephGDmU130_assertion description "[Both infliximab (chimeric anti-tumor necrosis factor [TNF]-alpha antibody) and etanercept (p75 TNF-alpha receptor/immunoglobulin G fusion protein) are effective against rheumatoid arthritis, but only infliximab induces clinical remission in Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718433.RAnXecGUpsCu0fqvb3SHPEV7ZRXfCKATw6mxpOephGDmU130_provenance.
NP471839.RA47ZVgMy9LZwSZo5HbFnG1xbxhbdbaPNJ68TySrB1F40130_assertion description "[Both infliximab (chimeric anti-tumor necrosis factor [TNF]-alpha antibody) and etanercept (p75 TNF-alpha receptor/immunoglobulin G fusion protein) are effective against rheumatoid arthritis, but only infliximab induces clinical remission in Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP471839.RA47ZVgMy9LZwSZo5HbFnG1xbxhbdbaPNJ68TySrB1F40130_provenance.
NP576711.RAgaEYRuATS03xJPRlGRlTxfT4-jwJSim8s4CUsIrB0Tg130_assertion description "[Both infliximab (chimeric anti-tumor necrosis factor [TNF]-alpha antibody) and etanercept (p75 TNF-alpha receptor/immunoglobulin G fusion protein) are effective against rheumatoid arthritis, but only infliximab induces clinical remission in Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP576711.RAgaEYRuATS03xJPRlGRlTxfT4-jwJSim8s4CUsIrB0Tg130_provenance.
NP798043.RAneRaH9pQ-ypfYS1eOsjK5A_Wn2DO52GlkvL4E4lrSFA130_assertion description "[Both infliximab (chimeric anti-tumor necrosis factor [TNF]-alpha antibody) and etanercept (p75 TNF-alpha receptor/immunoglobulin G fusion protein) are effective against rheumatoid arthritis, but only infliximab induces clinical remission in Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP798043.RAneRaH9pQ-ypfYS1eOsjK5A_Wn2DO52GlkvL4E4lrSFA130_provenance.
NP814378.RAhQHHrdMOzP7SQqaWfP-UoquNRb7agWz78Vtq1U_nPtA130_assertion description "[Both infliximab (chimeric anti-tumor necrosis factor [TNF]-alpha antibody) and etanercept (p75 TNF-alpha receptor/immunoglobulin G fusion protein) are effective against rheumatoid arthritis, but only infliximab induces clinical remission in Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814378.RAhQHHrdMOzP7SQqaWfP-UoquNRb7agWz78Vtq1U_nPtA130_provenance.
NP822970.RAg3fvLYpGuKDItHSNB4pqq0NnnabP-UmrdBBIH7M0vbU130_assertion description "[Both infliximab (chimeric anti-tumor necrosis factor [TNF]-alpha antibody) and etanercept (p75 TNF-alpha receptor/immunoglobulin G fusion protein) are effective against rheumatoid arthritis, but only infliximab induces clinical remission in Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822970.RAg3fvLYpGuKDItHSNB4pqq0NnnabP-UmrdBBIH7M0vbU130_provenance.
NP828667.RAt1ebd9CgHyYd2o8W7FXVk2_wPBTfWlSNuFwNZ0Tdu-E130_assertion description "[Both infliximab (chimeric anti-tumor necrosis factor [TNF]-alpha antibody) and etanercept (p75 TNF-alpha receptor/immunoglobulin G fusion protein) are effective against rheumatoid arthritis, but only infliximab induces clinical remission in Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP828667.RAt1ebd9CgHyYd2o8W7FXVk2_wPBTfWlSNuFwNZ0Tdu-E130_provenance.
NP509485.RAauVnsQIco0I_AnbdMTVydy0riQ-t0pg6EHLvqX9Vmo8130_assertion description "[Both infliximab (chimeric anti-tumor necrosis factor [TNF]-alpha antibody) and etanercept (p75 TNF-alpha receptor/immunoglobulin G fusion protein) are effective against rheumatoid arthritis, but only infliximab induces clinical remission in Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509485.RAauVnsQIco0I_AnbdMTVydy0riQ-t0pg6EHLvqX9Vmo8130_provenance.
NP935212.RA2orHc4VL6T6mm7FMhZimIJIAC_WyIV06xtX0vrPgG8E130_assertion description "[Both infliximab (chimeric anti-tumor necrosis factor [TNF]-alpha antibody) and etanercept (p75 TNF-alpha receptor/immunoglobulin G fusion protein) are effective against rheumatoid arthritis, but only infliximab induces clinical remission in Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP935212.RA2orHc4VL6T6mm7FMhZimIJIAC_WyIV06xtX0vrPgG8E130_provenance.
NP936224.RAwoi07yMTdzfMYzLn3nTI5jWwfJcjQp2QHSEZP0L9tYA130_assertion description "[Both infliximab (chimeric anti-tumor necrosis factor [TNF]-alpha antibody) and etanercept (p75 TNF-alpha receptor/immunoglobulin G fusion protein) are effective against rheumatoid arthritis, but only infliximab induces clinical remission in Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP936224.RAwoi07yMTdzfMYzLn3nTI5jWwfJcjQp2QHSEZP0L9tYA130_provenance.
assertion description "[Both infliximab (chimeric anti-tumor necrosis factor [TNF]-alpha antibody) and etanercept (p75 TNF-alpha receptor/immunoglobulin G fusion protein) are effective against rheumatoid arthritis, but only infliximab induces clinical remission in Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Both infliximab (chimeric anti-tumor necrosis factor [TNF]-alpha antibody) and etanercept (p75 TNF-alpha receptor/immunoglobulin G fusion protein) are effective against rheumatoid arthritis, but only infliximab induces clinical remission in Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP478875.RAQwu2zNZGT6jDW5VN62byHiOHPrVRhIXOlpDSOClDOCQ130_assertion description "[Both infliximab (chimeric anti-tumor necrosis factor [TNF]-alpha antibody) and etanercept (p75 TNF-alpha receptor/immunoglobulin G fusion protein) are effective against rheumatoid arthritis, but only infliximab induces clinical remission in Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478875.RAQwu2zNZGT6jDW5VN62byHiOHPrVRhIXOlpDSOClDOCQ130_provenance.
NP720092.RAE9pdNCMEtXLywFmxOhSIGBSzkHZgnP5vG1OTy9dEQ2g130_assertion description "[Both infliximab (chimeric anti-tumor necrosis factor [TNF]-alpha antibody) and etanercept (p75 TNF-alpha receptor/immunoglobulin G fusion protein) are effective against rheumatoid arthritis, but only infliximab induces clinical remission in Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP720092.RAE9pdNCMEtXLywFmxOhSIGBSzkHZgnP5vG1OTy9dEQ2g130_provenance.
NP777023.RAFtn7NEyhFxjcuHp4DVOKGXrSLfdfFgecC0JnWPbE2Og130_assertion description "[Both infliximab (chimeric anti-tumor necrosis factor [TNF]-alpha antibody) and etanercept (p75 TNF-alpha receptor/immunoglobulin G fusion protein) are effective against rheumatoid arthritis, but only infliximab induces clinical remission in Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP777023.RAFtn7NEyhFxjcuHp4DVOKGXrSLfdfFgecC0JnWPbE2Og130_provenance.
NP478874.RAppnCSnqSLzXa1WeUUylXCAwV5ihSvq0NEdFwBifRrVw130_assertion description "[Both infliximab (chimeric anti-tumor necrosis factor [TNF]-alpha antibody) and etanercept (p75 TNF-alpha receptor/immunoglobulin G fusion protein) are effective against rheumatoid arthritis, but only infliximab induces clinical remission in Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478874.RAppnCSnqSLzXa1WeUUylXCAwV5ihSvq0NEdFwBifRrVw130_provenance.